C14H8F2N4
270.24 g/mol
의약 중간체경고
5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile
CAS1350653-26-7EC811-889-7
용도 분류
의약 중간체
화합물 분류
헤테로사이클
주요 용도
의약 중간체
This compound is a fluorinated heterocyclic compound used as a pharmaceutical intermediate. Its structure features a pyrazolopyridine core with nitrile and fluorine substituents, making it relevant for small-molecule drug synthesis.
pharmaceutical intermediate for drug synthesisresearch compound for medicinal chemistry
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1350653-26-7
관련 화합물
참고동일 카테고리
2-(5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidine-4,5,6-triamine
CAS1350653-30-3
Pharmaceutical intermediate for vericiguat
참고동일 카테고리
2-(2-Phenyldiazenyl)propanedinitrile
CAS1350653-31-4
Pharmaceutical intermediate for Riociguat
참고동일 카테고리
Fmoc-L-norvaline
CAS135112-28-6
Protected amino acid for peptide synthesis
참고동일 카테고리
N-((Phenylmethoxy)carbonyl)-L-tyrosine methyl ester
CAS13512-31-7
Peptide synthesis protected amino acid
참고same scaffold
1-[(2-FLUOROPHENYL)METHYL]PYRAZOLO[3,4-B]PYRIDINE-3-CARBONITRILE
CAS256376-65-5
research compound
참고same scaffold
5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide hydrochloride
CAS1426309-48-9
Pharmaceutical intermediate for vericiguat synthesis
참고same scaffold
Ethyl 5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxylate
CAS1361232-72-5
pharmaceutical intermediate
참고same scaffold
1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide hydrochloride
CAS256499-19-1
research compound
안전 참조
경고
H400Very toxic to aquatic life
H410Very toxic to aquatic life with long lasting effects
식별자
IUPAC 이름
5-fluoro-1-[(2-fluorophenyl)methyl]pyrazolo[3,4-b]pyridine-3-carbonitrile
InChIKey
GPEUANAWZCBBHU-UHFFFAOYSA-N
SMILES
C1=CC=C(C(=C1)CN2C3=C(C=C(C=N3)F)C(=N2)C#N)F
동의어 목록 (5)
—